Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
DEA updates Form 222 to a new single-sheet format for ordering Schedule I and II controlled substances; technical amendments effective April 20, 2026.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 30, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. All DEA registrants who order Schedule I or II controlled substances using DEA Form 222. should confirm how it applies to their specific situation before acting. There is a time constraint attached: April 20, 2026 (effective date of the rule).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA Form 222 is now a single-sheet format instead of the previous multi-part form; technical amendments to the regulations.
Who it affects
All DEA registrants who order Schedule I or II controlled substances using DEA Form 222.
What you must do
Use the new single-sheet Form 222 for all orders of Schedule I and II controlled substances after the effective date.
Deadline
April 20, 2026 (effective date of the rule).
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
- Designation of P2P Methyl Glycidic Acid as a List I Chemical
- Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
- Exempt Chemical Preparations Under the Controlled Substances Act
- Revision of Applications for Manufacturing and Procurement Quotas